Tenaya Therapeutics appointed Eric Hyllengren as CFO effective July 13, 2026, following the planned retirement of Hiro Higa (Senior VP of Finance) in the third quarter. The update is operationally relevant but provides no direct financial guidance or earnings impact in the release.
Tenaya Therapeutics appointed Eric Hyllengren as CFO effective July 13, 2026, following the planned retirement of Hiro Higa (Senior VP of Finance) in the third quarter. The update is operationally relevant but provides no direct financial guidance or earnings impact in the release.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
